Endologix Inc. to Present at the Stephens Fall Investment Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Shelley Thunen, Chief Financial Officer, is scheduled to present at the Stephens Fall Investment Conference in New York.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC